CD44 and breast carcinoma: In contrast, in another study that evaluated 136 paraffin-embedded clinical specimens, no correlation was found between the prevalence of CD44+CD24− tumor cells and clinical outcome or survival [32], arguing against the significance of this phenotype in identifying cells with tumorigenic potential in human breast cancer [5].